EXOZ

Conviction 4HealthcareScan · Thu, Jun 25, 2026

EXOZ$7.14-7.27%

ResistanceSupportVol 14Insider sell

Vol MA14 9.12K

Mar 25Apr 13Apr 30May 18Jun 5Jun 24

EXOZYMES INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.exozymes.com ↗

Price7.14

Change-7.27%

Gap-0.97%

Rel volume0.42×

Avg volume7.53K

Avg $ vol60.33K

SMA 208.38

SMA 509.21

SMA 20010.44

Price vs 50-22.49%

Price vs 200-31.63%

MA stackbearish

50/200 cross—

Supertrenddown · 9.73

RSI (14)40

MACD hist-0.06

MACD cross—

Stoch %K / %D21 / 34

ADX (14)19

+DI / −DI15 / 28

RSI divergence—

MACD divergence—

ATR %+11.85%

ADR %9.46%

52w high16.50

52w low0.0000

From 52w high-56.73%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width51.92%

%B0.21

Donchian pos19.42%

Donchian high10.50

Donchian low6.33

AVWAP (52w high)10.28

vs AVWAP high-30.56%

AVWAP (52w low)10.54

vs AVWAP low-32.25%

OBV trendDown

Chaikin MF (20)-0.36

Today vs 20d0.42×

Avg vol (14d)9.12K

Avg vol (20d)7.53K

Avg $ vol (20d)60.33K

Market cap60.54M

RS 3m (vs SPY)-13.77%

RS 6m (vs SPY)-49.69%

RS line new highNo

Trend template1/8

Technical rank8.8

1 week-3.77%

1 month-28.02%

3 months-1.52%

6 months-41.95%

1 year-32.00%

YTD-35.03%

P/E-6.61

P/B39.62

P/S864.01

P/FCF-9.07

EPS-1.09

Div yield—

ROE-599.35%

ROA-227.89%

Debt/Eq—

Current1.32

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-56.26%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value59.1M

Revenue70.77K

Net income-2.37M

Gross profit—

Free cash flow-6.67M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out8.48M

Employees32

ListedWed, Nov 13, 2024

Free float2.52M

Float %29.7%

Short interest15.04K

Days to cover3.2d

Short volume8.2%

Squeeze score17 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank8.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance10.92

Support6.72

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in EXOZ

All disclosures →

No recent disclosed trades by Congress in EXOZ. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in EXOZ · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Korman Tyler Paz Chief Scientific Officer · COMMON STOCK · 2026-04-09	Sell	750	$8K	2026-04-09	2026-04-10
Korman Tyler Paz Chief Scientific Officer · COMMON STOCK · 2026-04-08	Sell	750	$8K	2026-04-08	2026-04-10

SEC filings

EDGAR filings in EXOZ · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.